Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Prediction of the clinical risk of drug-induced cholestatic liver injury from in vitro rat sandwich cultured hepatocytes assay.

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Poster
  • By: ITO, Kousei (Chiba University, Graduate School of Pharmaceuticak Sciences, Chiba, Japan)
  • Co-author(s): Nozaki, Mayuka (Chiba University, Chiba, Japan)
    Horie, Toshiharu (Teikyo Heisei University, Tokyo, Japan)
    Sekine, Shuichi (Chiba University, Chiba, Japan)
  • Abstract:

    [Background&Aim] It is important to assess the risk of drug induced liver injury (DILI) during the preclinical drug development process. We have established a rat sandwich cultured hepatocytes (rSCHs) based assay system to evaluate cholestatic DILI risk of each drug compound. However, it has not yet been confirmed if this in vitro assay system..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses